# OBIO (Orchestra BioMed Holdings, Inc.) - SEC EDGAR Financial Statements

> Orchestra BioMed Holdings, Inc. reported $31.21M in revenue and a net loss of $56.95M for the trailing twelve months ended September 30, 2026 (down 89.4% year over year), with a 99.6% gross margin and a -195.4% operating margin.

- Canonical: https://convexityos.com/fundamentals/OBIO
- Markdown: https://convexityos.com/fundamentals/OBIO.md
- SEC CIK: 0001814114
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:39 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001814114&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $31.21M | -89.4% YoY |
| Operating Income | TTM | -$60.97M | -195.4% margin |
| Net Income | TTM | -$56.95M | -182.5% net margin |
| Diluted EPS | TTM | -$0.88 | Split-adjusted |
| Free Cash Flow | TTM | -$64.18M | -205.7% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $101.9M | Total debt: $1.14M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | $33.48M | $2.64M | $2.76M | $3.53M | -- |
| Cost of Revenue | $190K | $204K | $186K | $211K | -- |
| **Gross Profit** | $33.29M | $2.43M | $2.57M | $3.32M | -- |
| Research & Development | $58.19M | $42.80M | $33.82M | $21.95M | -- |
| Selling, General & Admin | $26.91M | $23.93M | $20.26M | $14.03M | -- |
| **Operating Income** | -$51.81M | -$64.30M | -$51.51M | -$32.66M | -$395K |
| **EBITDA** | -$51.48M | -$63.99M | -$51.22M | -$32.44M | -- |
| Interest Income | -- | -- | -- | $345K | $16K |
| Interest Expense | -- | $297K | $1.40M | $1.30M | -- |
| Income Tax Expense | $0 | -- | -- | -- | -- |
| **Net Income** | -$52.70M | -$61.02M | -$49.12M | -$33.61M | -$379K |
| Basic EPS | -$1.11 | -$1.66 | -$1.48 | -$2.24 | -$0.02 |
| **Diluted EPS** | -$1.11 | -$1.66 | -$1.48 | -$2.24 | -$0.02 |
| Basic Shares Outstanding | 47.7M | 36.8M | 33.2M | 15.0M | 20.4M |
| Diluted Shares Outstanding | 47.7M | 36.8M | 33.2M | 15.0M | 20.4M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $91K | $88K | $110K | $30.92M | $861K | $836K | $868K | $253K |
| Cost of Revenue | $28K | $25K | $32K | $51K | $49K | $46K | $44K | $58K |
| **Gross Profit** | $63K | $63K | $78K | $30.87M | $812K | $790K | $824K | $195K |
| Research & Development | $17.73M | $16.59M | $15.78M | $16.82M | $14.03M | $13.85M | $13.48M | $10.97M |
| Selling, General & Admin | $5.62M | $5.83M | $6.37M | $7.29M | $7.10M | $6.26M | $6.26M | $5.90M |
| **Operating Income** | -$23.30M | -$22.36M | -$22.08M | $6.75M | -$20.31M | -$19.33M | -$18.92M | -$16.68M |
| **EBITDA** | -$23.20M | -$22.26M | -$21.99M | $6.84M | -$20.23M | -$19.25M | -$18.84M | -$16.59M |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | $297K |
| **Net Income** | -$18.75M | -$23.75M | -$20.69M | $6.25M | -$20.83M | -$19.36M | -$18.75M | -$16.16M |
| Basic EPS | -$0.30 | -$0.38 | -$0.33 | -- | -$0.40 | -$0.50 | -$0.49 | -- |
| **Diluted EPS** | -$0.30 | -$0.38 | -$0.33 | -- | -$0.40 | -$0.50 | -$0.49 | -- |
| Basic Shares Outstanding | 64.6M | 63.8M | 62.7M | -- | 52.2M | 38.4M | 38.2M | -- |
| Diluted Shares Outstanding | 64.6M | 63.8M | 62.7M | -- | 52.2M | 38.4M | 38.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $34.69M | $22.26M | $30.56M | $19.78M | $1.75M | $2.03M |
| Short-Term Investments | $71.82M | $44.55M | $56.97M | $63.91M | -- | -- |
| **Cash & Short-Term Investments** | $106.5M | $66.81M | $87.53M | $83.70M | $1.75M | $2.03M |
| Accounts Receivable, Net | $95K | $92K | $99K | $96K | -- | -- |
| Inventory | $310K | $173K | $146K | $276K | -- | -- |
| **Total Current Assets** | $107.9M | $69.17M | $89.11M | $84.69M | $1.80M | $2.15M |
| Property, Plant & Equipment, Net | $1.72M | $1.38M | $1.28M | $1.49M | -- | -- |
| Long-Term Investments | $4.90M | $3.30M | -- | -- | -- | -- |
| **Total Non-Current Assets** | $6.95M | $7.00M | $6.10M | $10.88M | $160.0M | $160.0M |
| **Total Assets** | $114.9M | $76.17M | $95.21M | $95.57M | $161.8M | $162.2M |
| Accounts Payable | $6.09M | $5.13M | $2.90M | $3.97M | $1.4K | $14K |
| Deferred Revenue (Current) | -- | $4.44M | $2.51M | $6.44M | -- | -- |
| **Total Current Liabilities** | $16.74M | $16.21M | $11.21M | $18.57M | $166K | $119K |
| Long-Term Debt | $15.00M | $15.00M | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | -- | $10.99M | $14.92M | $13.10M | -- | -- |
| Other Non-Current Liabilities | $308K | $40K | -- | $196K | -- | -- |
| **Total Non-Current Liabilities** | $34.74M | $27.01M | $15.96M | $24.47M | $5.60M | $5.60M |
| **Total Liabilities** | $51.48M | $43.22M | $27.17M | $43.04M | $5.77M | $5.72M |
| **Total Debt (incl. Leases)** | $16.69M | $17.24M | $1.69M | $2.38M | -- | -- |
| Common Stock | $6.0K | $4.0K | $4.0K | $2.0K | $445 | $445 |
| Retained Earnings | -$362.6M | -$309.9M | -$248.9M | -$199.7M | -$3.94M | -$3.56M |
| Accumulated Other Comp. Income | $60K | $52K | -$10K | -$8.0K | -- | -- |
| **Total Stockholders' Equity** | -- | -- | -- | $52.53M | -$19.78M | -$3.56M |
| Total Equity | $53.57M | $32.96M | $68.04M | $52.53M | -$19.78M | -$3.56M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $27.76M | $20.47M | $28.37M | $34.69M | $42.01M | $18.75M | $18.35M | $22.26M |
| Short-Term Investments | $74.15M | $89.49M | $66.03M | $71.82M | $53.81M | $15.18M | $31.54M | $44.55M |
| **Cash & Short-Term Investments** | $101.9M | $110.0M | $94.40M | $106.5M | $95.82M | $33.92M | $49.88M | $66.81M |
| Accounts Receivable, Net | $56K | $51K | $84K | $95K | $52K | $83K | $89K | $92K |
| Inventory | $221K | $250K | $277K | $310K | $365K | $185K | $135K | $173K |
| **Total Current Assets** | $103.2M | $111.2M | $96.21M | $107.9M | $97.77M | $35.88M | $51.90M | $69.17M |
| Property, Plant & Equipment, Net | $2.28M | $2.04M | $1.85M | $1.72M | $1.59M | $1.37M | $1.41M | $1.38M |
| Long-Term Investments | $787K | $7.10M | $3.40M | $4.90M | $4.10M | $1.30M | $1.90M | $3.30M |
| **Total Non-Current Assets** | $4.57M | $4.46M | $4.45M | $6.95M | $7.04M | $6.94M | $7.15M | $7.00M |
| **Total Assets** | $107.7M | $115.7M | $100.7M | $114.9M | $104.8M | $42.83M | $59.05M | $76.17M |
| Accounts Payable | $5.03M | $6.13M | $6.31M | $6.09M | $8.47M | $5.31M | $5.56M | $5.13M |
| Deferred Revenue (Current) | -- | -- | -- | -- | $4.65M | $4.46M | $3.94M | $4.44M |
| **Total Current Liabilities** | $14.23M | $13.47M | $13.69M | $16.74M | $20.66M | $17.06M | $15.49M | $16.21M |
| Long-Term Debt | -- | -- | $15.00M | $15.00M | $15.00M | $15.00M | $15.00M | $15.00M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | $8.66M | $9.57M | $10.75M | $10.99M |
| Other Non-Current Liabilities | $456K | $397K | $367K | $308K | $248K | $189K | $99K | $40K |
| **Total Non-Current Liabilities** | $74.76M | $72.81M | $36.00M | $34.74M | $40.41M | $25.47M | $26.70M | $27.01M |
| **Total Liabilities** | $88.99M | $86.28M | $49.69M | $51.48M | $61.07M | $42.53M | $42.19M | $43.22M |
| **Total Debt (incl. Leases)** | $1.14M | $1.33M | $16.52M | $16.69M | $16.83M | $16.97M | $17.11M | $17.24M |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K |
| Retained Earnings | -$425.8M | -$407.0M | -$383.3M | -$362.6M | -$368.8M | -$348.0M | -$328.6M | -$309.9M |
| Accumulated Other Comp. Income | -$153K | -$81K | -$40K | $60K | $45K | $16K | $37K | $52K |
| Total Equity | $7.78M | $19.32M | $41.19M | $53.57M | $43.74M | $295K | $16.86M | $32.96M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$52.70M | -$61.02M | -$49.12M | -$33.61M | -$379K |
| Depreciation & Amortization | $327K | $308K | $287K | $222K | -- |
| Stock-Based Compensation | $11.98M | $10.62M | $7.62M | $3.38M | -- |
| Change in Receivables | -$3.0K | $22K | -$3.0K | $25K | -- |
| Change in Inventory | -$137K | -$28K | $131K | -$208K | -- |
| Change in Payables | -- | -- | -- | $376K | -$12K |
| **Operating Cash Flow** | -$48.96M | -$50.56M | -$46.13M | -$29.29M | -$272K |
| Capital Expenditure | -$489K | -$289K | -$78K | -$591K | -- |
| **Free Cash Flow** | -$49.45M | -$50.85M | -$46.20M | -$29.88M | -- |
| Purchases of Investments | -$76.31M | -$72.65M | -$142.0M | -$63.32M | -- |
| **Investing Cash Flow** | -$26.94M | $13.09M | $10.69M | -$64.12M | -- |
| Dividends Paid | -- | -- | -- | -$20.00M | -- |
| **Financing Cash Flow** | $88.33M | $29.17M | $46.22M | $103.3M | -- |
| **Net Change in Cash** | $12.43M | -$8.30M | $10.78M | $9.85M | -$272K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$18.75M | -$23.75M | -$20.69M | $6.25M | -$20.83M | -$19.36M | -$18.75M | -$16.16M |
| Depreciation & Amortization | $101K | $96K | $90K | $82K | $81K | $81K | $83K | $84K |
| Stock-Based Compensation | $2.29M | $2.50M | $2.85M | $2.75M | $3.01M | $3.25M | $2.96M | $2.90M |
| Change in Receivables | -$5.0K | $33K | $11K | -$43K | $31K | $6.0K | $3.0K | $38K |
| Change in Inventory | $29K | $27K | $33K | $55K | -$181K | -$49K | $38K | $60K |
| **Operating Cash Flow** | -$19.54M | -$19.33M | -$22.17M | -$2.27M | -$14.55M | -$15.53M | -$16.62M | -$13.54M |
| Capital Expenditure | -$398K | -$254K | -$184K | -$33K | -$310K | -$34K | -$112K | -$106K |
| **Free Cash Flow** | -$19.94M | -$19.59M | -$22.35M | -$2.30M | -$14.86M | -$15.56M | -$16.73M | -$13.64M |
| Purchases of Investments | -$6.49M | -$43.00M | -$13.12M | -$25.63M | -$47.78M | $0 | -$2.90M | -$20.27M |
| **Investing Cash Flow** | $20.96M | -$23.31M | $10.32M | -$17.71M | -$38.58M | $16.36M | $13.00M | -$3.75M |
| **Financing Cash Flow** | $5.86M | $34.75M | $5.53M | $12.66M | $76.40M | -$428K | -$296K | $13.95M |
| **Net Change in Cash** | $7.29M | -$7.89M | -$6.32M | -$7.32M | $23.26M | $401K | -$3.91M | -$3.34M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 99.4% | 92.3% | 93.3% | 94.0% | -- |
| **Operating Margin** | -154.7% | -2437.5% | -1866.2% | -924.3% | -- |
| **Net Profit Margin** | -157.4% | -2313.3% | -1779.7% | -951.3% | -- |
| Return on Equity (ROE) | -- | -- | -- | -64.0% | -- |
| Return on Assets (ROA) | -45.9% | -80.1% | -51.6% | -35.2% | -0.2% |
| Current Ratio | 6.45x | 4.27x | 7.95x | 4.56x | 10.88x |
| Quick Ratio | 6.43x | 4.26x | 7.94x | 4.55x | 10.60x |
| Debt to Equity | -- | -- | -- | 0.05x | -- |
| **Revenue Growth (YoY)** | +1169.2% | -4.4% | -21.9% | -- | -- |
| Gross Profit Growth (YoY) | +1267.8% | -5.4% | -22.5% | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 99.6% | 99.5% | 99.5% | 99.4% | 93.0% | 92.7% | 92.6% | 92.3% |
| **Operating Margin** | -195.4% | -181.4% | -168.0% | -154.7% | -2669.9% | -2420.8% | -2383.9% | -2437.5% |
| **Net Profit Margin** | -182.5% | -184.6% | -167.0% | -157.4% | -2665.0% | -2367.5% | -2297.9% | -2313.3% |
| Return on Assets (ROA) | -52.9% | -51.0% | -54.3% | -45.9% | -71.7% | -162.8% | -112.3% | -80.1% |
| Current Ratio | 7.25x | 8.26x | 7.03x | 6.45x | 4.73x | 2.10x | 3.35x | 4.27x |
| Quick Ratio | 7.24x | 8.24x | 7.01x | 6.43x | 4.72x | 2.09x | 3.34x | 4.26x |
| **Revenue Growth (YoY)** | -89.4% | -89.5% | -87.3% | +12120.2% | -12.8% | +7.5% | +40.0% | -3.4% |
| Gross Profit Growth (YoY) | -92.2% | -92.0% | -90.5% | +15728.7% | -11.6% | +7.6% | +40.6% | -9.3% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
